Financhill
Sell
37

MREO Quote, Financials, Valuation and Earnings

Last price:
$2.40
Seasonality move :
48.12%
Day range:
$2.33 - $2.58
52-week range:
$1.58 - $5.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.08x
Volume:
996.4K
Avg. volume:
1.7M
1-year change:
-24.84%
Market cap:
$370.5M
Revenue:
$10M
EPS (TTM):
-$0.30

Earnings Data

Next earnings date for MREO
May 15
2025
Most recent earnings per share
-$0.05
Missed by $0.04
(Mar 26/2025)
Consensus Estimate
-$0.01
(Mar 26/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MREO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $6.3M -- -- -$0.02 --
05/15/2025 Q1 $15.3M -- -- -$0.01 --
03/26/2025 Q4 -- -- -$0.05 -$0.01 -$0.04
11/12/2024 Q3 -- -- -$0.10 -$0.02 -$0.08
08/13/2024 Q2 -- -- -$0.10 -$0.01 -$0.09
05/15/2024 Q1 -- -- -$0.05 -- --
12/31/2023 Q4 -- $1M -$0.05 -- --
06/30/2023 Q2 -- -- -$0.03 -- --
03/31/2022 Q4 -- -- -- -- --
11/08/2021 Q3 -- -- -- -- --
06/30/2021 Q2 -- -- -- -- --
03/31/2021 Q1 -- -- -- -- --

Mereo BioPharma Group PLC Earnings Questions

  • How Much did Mereo BioPharma Group PLC Generate in Revenue Last Quarter?

    Mereo BioPharma Group PLC reported -- worth of top line sales in its most recent quarter.

  • Did Mereo BioPharma Group PLC Beat Earnings Last Quarter?

    Mereo BioPharma Group PLC announced earnings per share of -$0.05 which represents a miss of analyst forecast a -$0.01 per share.

  • Is Mereo BioPharma Group PLC Profitable?

    Mereo BioPharma Group PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Mereo BioPharma Group PLC EPS Next Year?

    Mereo BioPharma Group PLC's earnings are forecast to decrease from -$0.30 per share to -$0.06 per share next year representing a decrease of -83.45%.

  • When is Mereo BioPharma Group PLC's Earnings Date?

    Mereo BioPharma Group PLC's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is down 0% over the past day.

Buy
53
SRPT alert for May 7

Sarepta Therapeutics [SRPT] is down 21.54% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock